The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial
{{output}}
Adverse drug events (ADEs) account for a significant mortality, morbidity, and cost burden. Pharmacogenetic testing has the potential to reduce ADEs and inefficacy. The objective of this INGENIOUS trial (NCT02297126) analysis was to determine whether conductin... ...
